207 related articles for article (PubMed ID: 35313878)
21. Simultaneous silencing Aurora-A and UHRF1 inhibits colorectal cancer cell growth through regulating expression of DNMT1 and STAT1.
Han J; Chen X; Xu J; Chu L; Li R; Sun N; Jiang Z; Liu H; Ge X; Zheng J; Yang J; Ikezoe T
Int J Med Sci; 2021; 18(15):3437-3451. PubMed ID: 34522170
[TBL] [Abstract][Full Text] [Related]
22. Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer.
Chen J; Chen S; Zhuo L; Zhu Y; Zheng H
Cell Death Dis; 2020 Mar; 11(3):173. PubMed ID: 32144236
[TBL] [Abstract][Full Text] [Related]
23. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
[TBL] [Abstract][Full Text] [Related]
24. PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation.
Ma J; Yang Y; Fu Y; Guo F; Zhang X; Xiao S; Zhu W; Huang Z; Zhang J; Chen J
Theranostics; 2018; 8(11):3022-3037. PubMed ID: 29896300
[No Abstract] [Full Text] [Related]
25. Single-cell RNA sequencing reveals distinct cellular factors for response to immunotherapy targeting CD73 and PD-1 in colorectal cancer.
Kim M; Min YK; Jang J; Park H; Lee S; Lee CH
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34253638
[TBL] [Abstract][Full Text] [Related]
26. Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity.
Ibrahim A; Hugerth LW; Hases L; Saxena A; Seifert M; Thomas Q; Gustafsson JÅ; Engstrand L; Williams C
Int J Cancer; 2019 Jun; 144(12):3086-3098. PubMed ID: 30515752
[TBL] [Abstract][Full Text] [Related]
27. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
[TBL] [Abstract][Full Text] [Related]
28. Smad2/3 linker phosphorylation is a possible marker of cancer stem cells and correlates with carcinogenesis in a mouse model of colitis-associated colorectal cancer.
Suzuki R; Fukui T; Kishimoto M; Miyamoto S; Takahashi Y; Takeo M; Mitsuyama T; Sakaguchi Y; Uchida K; Nishio A; Okazaki K
J Crohns Colitis; 2015 Jul; 9(7):565-74. PubMed ID: 25908723
[TBL] [Abstract][Full Text] [Related]
29. STAT1 Inhibits MiR-181a Expression to Suppress Colorectal Cancer Cell Proliferation Through PTEN/Akt.
Zhang X; Li X; Tan F; Yu N; Pei H
J Cell Biochem; 2017 Oct; 118(10):3435-3443. PubMed ID: 28322462
[TBL] [Abstract][Full Text] [Related]
30. [Expression of tyrosine and threonine protein kinase in carcinogenic process of colorectal cancer and its relationship with prognosis].
Zhang XL; Han WX; Ma YM; Baohan HW; Zhao XH; Wang HY
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):172-177. PubMed ID: 28316214
[No Abstract] [Full Text] [Related]
31. Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer.
Wei TT; Lin YT; Chen WS; Luo P; Lin YC; Shun CT; Lin YH; Chen JB; Chen NW; Fang JM; Wu MS; Yang KC; Chang LC; Tai KY; Liang JT; Chen CC
EBioMedicine; 2016 Aug; 10():124-36. PubMed ID: 27448759
[TBL] [Abstract][Full Text] [Related]
32. Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
Chiriac MT; Buchen B; Wandersee A; Hundorfean G; Günther C; Bourjau Y; Doyle SE; Frey B; Ekici AB; Büttner C; Weigmann B; Atreya R; Wirtz S; Becker C; Siebler J; Neurath MF
Gastroenterology; 2017 Jul; 153(1):123-138.e8. PubMed ID: 28342759
[TBL] [Abstract][Full Text] [Related]
33. An Optimized Protocol of Azoxymethane-Dextran Sodium Sulfate Induced Colorectal Tumor Model in Mice.
Liang X; Hu JN; He JM
Chin Med Sci J; 2019 Nov; 34(4):281-288. PubMed ID: 33906714
[TBL] [Abstract][Full Text] [Related]
34. The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth.
Nivarthi H; Gordziel C; Themanns M; Kramer N; Eberl M; Rabe B; Schlederer M; Rose-John S; Knösel T; Kenner L; Freund P; Aberger F; Han X; Kralovics R; Dolznig H; Jennek S; Friedrich K; Moriggl R
Oncotarget; 2016 Aug; 7(32):51096-51106. PubMed ID: 27191495
[TBL] [Abstract][Full Text] [Related]
35. Discovery of potential colorectal cancer serum biomarkers through quantitative proteomics on the colonic tissue interstitial fluids from the AOM-DSS mouse model.
Wang Y; Shan Q; Hou G; Zhang J; Bai J; Lv X; Xie Y; Zhu H; Su S; Li Y; Zi J; Lin L; Han W; Zhao X; Wang H; Xu N; Wu L; Lou X; Liu S
J Proteomics; 2016 Jan; 132():31-40. PubMed ID: 26581642
[TBL] [Abstract][Full Text] [Related]
36. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
[TBL] [Abstract][Full Text] [Related]
37. Colitis-accelerated colorectal cancer and metabolic dysregulation in a mouse model.
Gao Y; Li X; Yang M; Zhao Q; Liu X; Wang G; Lu X; Wu Q; Wu J; Yang Y; Yang Y; Zhang Y
Carcinogenesis; 2013 Aug; 34(8):1861-9. PubMed ID: 23615396
[TBL] [Abstract][Full Text] [Related]
38. RAD51AP1 Loss Attenuates Colorectal Cancer Stem Cell Renewal and Sensitizes to Chemotherapy.
Bridges AE; Ramachandran S; Tamizhmani K; Parwal U; Lester A; Rajpurohit P; Morera DS; Hasanali SL; Arjunan P; Jedeja RN; Patel N; Martin PM; Korkaya H; Singh N; Manicassamy S; Prasad PD; Lokeshwar VB; Lokeshwar BL; Ganapathy V; Thangaraju M
Mol Cancer Res; 2021 Sep; 19(9):1486-1497. PubMed ID: 34099522
[TBL] [Abstract][Full Text] [Related]
39. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
40. CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity.
Xiang Y; Mata-Garrido J; Fu Y; Desterke C; Batsché E; Hamaï A; Sedlik C; Sereme Y; Skurnik D; Jalil A; Onifarasoaniaina R; Frapy E; Beche JC; Alao R; Piaggio E; Arbibe L; Chang Y
EMBO Mol Med; 2024 Jun; 16(6):1404-1426. PubMed ID: 38684864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
